MIAMI LAKES, Fla., Feb. 20 /PRNewswire/ -- Cordis Corporation, a worldwide leader in developing and manufacturing interventional vascular technology, announced today the launch of the REGATTA(TM) Steerable Guidewire family in the United States. The launch is marked by the introduction this week of 12 selections of the REGATTA(TM) Steerable Guidewire and two choices of the REGATTA(TM) SB Steerable Guidewire. In April, the company will also add the REGATTA(TM) HS Steerable Guidewire in two selections.
Cordis is offering the REGATTA(TM) Guidewire family to provide tailored solutions for the placement of catheters and other interventional devices in coronary arteries. The REGATTA(TM) Guidewires are all-purpose guidewires; the REGATTA(TM) SB Guidewires are designed to facilitate access to side branches; and the REGATTA(TM) HS Guidewires include features that ease placement in highly narrowed arteries. The different selections for each version refer to variations in tip type, tip profile, lateral support and/or wire length.
“When I tested the REGATTA(TM) Guidewire family, I was pleased to see each of them perform well under challenging circumstances,” said Emerson C. Perin, M.D., Ph.D., F.A.C.C., Director, New Interventional Cardiovascular Technology, Texas Heart Institute at St. Luke’s Episcopal Hospital in Houston, Texas. “It is good to see Cordis back in the cath lab with a strong and innovative line of steerable guidewires.”
The launch marks a major milestone in the company’s efforts to offer a comprehensive product portfolio to meet the needs of interventionalists and patients.
“With the REGATTA(TM) Guidewire family, we increase our ability to help physicians address the specific needs of patients,” said David E. Kandzari, M.D., F.A.C.C., F.S.C.A.I., Chief Medical Officer, Cordis Cardiology Division of Cordis Corporation.
All versions in the REGATTA(TM) Guidewire family feature a next-generation hydrophilic coating technology that prevents swelling and a single-piece steel core wire that enhances torque. In addition, the REGATTA(TM) Guidewires and the REGATTA(TM) HS Guidewires offer a unique microridge design for additional torque control. The REGATTA(TM) HS Guidewires also feature a rounded wedge tip that facilitates the introduction of the wire in highly narrowed lesions, and the REGATTA(TM) SB Guidewires come with an innovative shaping ribbon that is oriented in the plane of a J-shape, helping physicians locate and access side branches.
The U.S. launch of the REGATTA(TM) Guidewire family will be followed by market introductions outside the United States starting in a week. Cordis is the worldwide distributor of the REGATTA(TM) Guidewire family as a result of an agreement between Cordis and Brivant Limited signed in 2006.
About Cordis Corporation
Cordis Corporation, a Johnson & Johnson company, is a worldwide leader in developing and manufacturing interventional vascular technology. Through the company’s innovation, research and development, physicians worldwide are better able to treat the millions of patients who suffer from vascular disease. For more information, visit http://www.cordis.com.
Cordis Corporation
CONTACT: Mariela Melendez of Cordis Corporation, +1-786-313-2776, cell,+1-786-218-4084, mmelen10@crdus.jnj.com; or Todd Ringler of Edelman, cell,+1-617-872-1235, todd.ringler@edelman.com, for Cordis Corporation
Web site: http://www.cordis.com//